Innovation Pharmaceuticals Inc (IPIX): unless it's to combine remdesivir wi...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Monday, 11/16/2020 9:17:36 AM

Monday, November 16, 2020 9:17:36 AM

unless it's to combine remdesivir with brilacidin; that would generate a big pop as well as prophylactic inhaler (2 items noted in the preprint)

the above is all IMHO (consider this my safe harbor statement)

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM

InvestorsHub NewsWire

FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM

Only $200 per official company press release!